Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. (BLPH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BLPH · as of Dec 31, 2023
Ownership Breakdown
2
Institutional Holders
▼ 21 vs Q3
$6,370
Total Inst. Value
▼ $500,190 vs Q3
12.23M
Shares Outstanding
freeFloat 91.80%
209,600
13F Shares Held
▼ 1.06M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BLPH largest shareholders · institutional ownership
Q4 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 199.6K | 1.63% | 1.63% | $6.00M | Feb 13, 2024 | ▼ 183.6K |
RAYMOND JAMES & ASSOCIATES pharmaceutical preparations | 10.0K | 8.17% | 8.17% | $370,000 | Jan 16, 2024 | — held |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Mar 11, 2024 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 16, 2024 | EXIT |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2024 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2024 | EXIT |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 9, 2024 | EXIT |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 9, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2023 vs prior quarter
Q4 2023
0
Increased
+0 shares0
New Positions
first time holders1
Decreased
−183.6K shares20
Sold Out
fully exitedNet shares change (top 50)
183.6K
+0 / −183.6K
Net new holders
-21
0 new / 20 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BLPH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
13
Sell transactions
0.23
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Puissance Capital Management LP 10 percent owner | Oct 13, 2023 | Sale | 1,076,841 | $0.10 | $111.8K | 0 | Form 4 ↗ |
Amin Naseem director | Jun 7, 2023 | Award | 47,578 | — | — | 291.9K | Form 4 ↗ |
Fernandes Peter See Remarks | Jun 7, 2023 | Award | 100,000 | $0.83 | $82.6K | 100.0K | Form 4 ↗ |
Shah Parag Suresh VP of Business Operations | Jun 7, 2023 | Award | 50,000 | $0.83 | $41.3K | 50.0K | Form 4 ↗ |
Dekker Martin See Remarks | Jun 7, 2023 | Award | 50,000 | $0.83 | $41.3K | 50.0K | Form 4 ↗ |
Bruder Scott P director | Jun 7, 2023 | Award | 14,607 | $0.83 | $12.1K | 14.6K | Form 4 ↗ |
Kim Bobae VP Reg. Affairs & Quality | Jun 7, 2023 | Award | 50,000 | $0.83 | $41.3K | 50.0K | Form 4 ↗ |
Wang Theodore T director | Jun 7, 2023 | Award | 14,607 | $0.83 | $12.1K | 14.6K | Form 4 ↗ |
Cloyd Mary Ann director | Jun 7, 2023 | Award | 14,607 | $0.83 | $12.1K | 14.6K | Form 4 ↗ |
Teufel Crispin director | Jun 7, 2023 | Award | 14,607 | $0.83 | $12.1K | 14.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bellerophon Therapeutics, Inc. (BLPH) is primarily owned by institutional investors, who hold approximately 1.7% of total shares outstanding. Company insiders own approximately 8.20%, while retail and public investors account for the remaining 90.09%.
The largest institutional shareholder of Bellerophon Therapeutics, Inc. is ACADIAN ASSET MANAGEMENT LLC, holding approximately 199,600 shares — equal to 1.63% of outstanding shares — as of December 31, 2023.
A total of 2 institutional investors currently hold BLPH stock, with a combined institutional value of approximately $6,370 as of the most recent 13F filing period.
Frequently asked questions
BLPH ownershipBellerophon Therapeutics, Inc. (BLPH) is primarily owned by institutional investors, who hold approximately 1.7% of shares. The largest shareholder is ACADIAN ASSET MANAGEMENT LLC with a 1.63% stake. Company insiders hold 8.20%. Data sourced from SEC Form 13F as of December 31, 2023.